查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1757449

血清分离凝胶市场：全球产业分析、市场规模、份额、成长、趋势与未来预测（2025-2032）

Serum Separation Gel Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 197 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球血清分离凝胶市场的综合报告，详细分析了关键市场动态，包括驱动因素、新兴趋势、机会和挑战。该报告深入分析了市场格局，帮助相关人员做出明智的决策。

关键见解

  • 血清分离凝胶市场规模（2025年）：78.8亿美元
  • 市场规模预测（以金额为准，2032年）：125.6亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：6%

血清分离凝胶市场：分析范围

血清分离凝胶市场涵盖用于在离心过程中分离血清和血细胞的采血管材料。这些凝胶因其高效、无污染的血液分析而被广泛应用于诊断实验室、医院和研究机构。慢性病和感染疾病的日益流行，以及对高效可靠诊断程序的重视，推动了血清分离凝胶的需求。此外，凝胶配方和试管设计的技术进步也促进了样品稳定性和操作性的提高，也推动了血清分离凝胶市场的发展。

市场成长动力：

全球血清分离凝胶市场的成长动力源于对先进诊断技术日益增长的需求，而这些需求源于心血管疾病、糖尿病和癌症等慢性疾病负担的日益加重。老年人口的不断增长，使得老年人更容易出现需要频繁进行诊断检查的疾病，这进一步扩大了市场需求。此外，新兴经济体医疗基础设施的不断改善、诊断实验室和血库数量的不断增加，也推动了血清分离凝胶的普及率不断上升。凝胶配方的改进，使其能够提高分离效率并延长样品稳定性，也推动了市场的成长。

市场限制：

儘管成长前景看好，血清分离凝胶市场仍面临一些挑战。先进凝胶配方的高昂製造成本可能会阻碍其市场渗透，尤其是在价格敏感的地区。此外，凝胶干扰某些分析测试的风险可能会影响测试准确性，并限制某些凝胶类型的应用。监管合规性和品管问题，尤其是在新兴市场，也可能对产品在全球市场的持续供应和接受度构成障碍。

市场机会：

由于技术创新和向未开发地区的扩张，血清分离凝胶市场提供了巨大的成长机会。奈米技术和生物相容性材料的发展为开发性能和安全性更高的下一代凝胶提供了潜力。亚太、南美和拉丁美洲的新兴经济体由于医疗支出的增加和诊断基础设施的改善，为市场扩张提供了肥沃的土壤。凝胶製造商和诊断设备供应商之间的合作以及研发投入进一步推动了技术创新，使市场参与者能够更有效地满足不断变化的医疗需求。

本报告回答的关键问题

  • 推动全球血清分离凝胶市场成长的关键因素有哪些？
  • 血清分离胶最需要的地区和应用领域有哪些？
  • 诊断技术的进步如何影响市场动态？
  • 血清分离凝胶市场的主要企业有哪些？他们采用什么策略来保持竞争力？
  • 全球血清分离凝胶市场的新兴趋势和未来预测是什么？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
  • COVID-19影响分析
  • 预测因子：相关性和影响力

第三章 加值分析

  • 监管状况
  • 管道分析
  • 依产品类型分析采用状况
  • 价值链分析
  • 厂商主要促销策略
  • PESTLE分析
  • 波特五力分析

第四章 全球血清分离凝胶市场展望

  • 主要亮点
    • 市场规模及与前一年同期比较率（以金额为准）
    • 绝对的商机
  • 市场规模分析与预测（以金额为准）
    • 历史市场规模分析（以金额为准，2019-2024）
    • 市场规模分析与预测（以金额为准，2025-2032）
  • 全球血清分离凝胶市场按产品类型分類的前景
    • 简介/主要发现
    • 按产品类型分類的历史市场规模分析（以金额为准，2019-2024 年）
    • 按产品类型分類的市场规模分析与预测（以金额为准，2025-2032 年）
      • 带有集成管的血清分离凝胶
      • 一体化无管血清分离胶
    • 市场吸引力分析：按产品类型
  • 全球血清分离凝胶市场依最终用途展望
    • 简介/主要发现
    • 按最终用途分類的历史市场规模分析（以金额为准，2019-2024 年）
    • 按最终用途分類的市场规模分析和预测（以金额为准，2025-2032 年）
      • 医院和诊所
      • 诊断实验室
      • 血库
      • 製药和生物技术公司
      • 其他的
    • 市场吸引力分析：按最终用途

第五章 全球血清分离凝胶市场区域展望

  • 主要亮点
  • 按地区分類的历史市场规模分析（以金额为准，2019-2024 年）
  • 各地区市场规模分析及预测（以金额为准，2025-2032）
    • 北美洲
    • 欧洲
    • 亚太地区
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：区域

第六章北美血清分离凝胶市场展望：

第七章欧洲血清分离凝胶市场展望：

第八章东亚精华分离凝胶市场展望：

第九章南亚和大洋洲精华分离凝胶市场展望：

第 10 章拉丁美洲血清分离凝胶市场展望：

第十一章中东与非洲血清分离凝胶市场展望：

第十二章竞争格局

  • 市场占有率分析（2025年）
  • 市场结构
    • 竞争强度图：按市场
    • 竞争仪錶板
  • 公司简介（详情：概述、财务状况、策略、最新发展）
    • Merck KGaA
    • Qiagen NV
    • Cardinal Health Inc.
    • Medtronic PLC
    • Bio-Rad Laboratories
    • Microfluidics International Corporation
    • BioVision, Inc.
    • Danaher Corporation
    • Becton Dickinson &Company
    • F. Hoffmann-La Roche Ltd.

第十三章 附录

  • 分析方法
  • 分析前提条件
  • 首字母缩写和简称
简介目录
Product Code: PMRREP35425

Persistence Market Research has recently released a comprehensive report on the global Serum Separation Gel Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Serum Separation Gel Market Size (2025E): US$ 7.88 Bn
  • Projected Market Value (2032F): US$ 12.56 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6%

Serum Separation Gel Market - Report Scope:

The serum separation gel market encompasses materials used in blood collection tubes to separate serum from blood cells during centrifugation. These gels are widely employed in diagnostic labs, hospitals, and research settings, owing to their efficiency in facilitating accurate and contamination-free blood analysis. The increasing prevalence of chronic and infectious diseases, along with a growing emphasis on efficient and reliable diagnostic procedures, is fueling the demand for serum separation gels. The market is also benefiting from technological advancements in gel formulations and tube designs that enhance sample stability and handling.

Market Growth Drivers:

The growth of the global serum separation gel market is driven by the rising demand for advanced diagnostic techniques due to the increasing burden of chronic diseases such as cardiovascular disorders, diabetes, and cancer. The growth in geriatric population, which is more susceptible to health conditions requiring frequent diagnostic testing, is further augmenting market demand. Additionally, the expansion of healthcare infrastructure across emerging economies and the increasing number of diagnostic laboratories and blood banks are contributing to higher adoption rates of serum separation gels. Improvements in gel composition that allow for better separation efficiency and longer sample stability are also encouraging market growth.

Market Restraints:

Despite a favorable growth outlook, the serum separation gel market faces certain challenges. High manufacturing costs associated with advanced gel formulations can hinder market penetration, especially in price-sensitive regions. Moreover, the risk of gel interference with certain analytical tests may affect test accuracy and limit the application of some gel types. Regulatory compliance and quality control issues, particularly in developing nations, may also pose barriers to consistent product availability and acceptance in global markets.

Market Opportunities:

The serum separation gel market presents numerous growth opportunities fueled by innovation and expansion into untapped regions. Advances in nanotechnology and bio-compatible materials offer potential for the development of next-generation gels with enhanced performance and safety profiles. Emerging economies in Asia Pacific, South Asia, and Latin America offer fertile ground for market expansion due to growing healthcare expenditure and improvements in diagnostic infrastructure. Collaborations between gel manufacturers and diagnostic equipment providers, along with investments in R&D, can further boost innovation and enable market players to address evolving healthcare demands more effectively.

Key Questions Answered in the Report:

  • What are the primary factors driving the global serum separation gel market's growth?
  • Which regions and application segments are experiencing the highest demand for serum separation gels?
  • How are advancements in diagnostic technologies influencing market dynamics?
  • Who are the key players in the serum separation gel market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future projections for the global serum separation gel market?

Competitive Intelligence and Business Strategy:

Leading companies in the global serum separation gel market, such as Qiagen N.V., Cardinal Health Inc., Medtronic PLC, Bio-Rad Laboratories, and Becton Dickinson & Company, are focusing on expanding their product portfolios and enhancing the performance of their gel-based separation products. These players are investing in research and development to create gels with faster separation time, improved stability, and compatibility with automated testing systems. Strategic partnerships with diagnostic labs and healthcare institutions, along with an emphasis on global distribution networks, are key tactics being employed to strengthen market presence.

Companies Covered in This Report:

  • Qiagen N.V.
  • Cardinal Health Inc.
  • Medtronic PLC
  • Bio-Rad Laboratories
  • Microfluidics International Corporation
  • BioVision, Inc.
  • Danaher Corporation
  • Becton Dickinson & Company
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA

Market Segmentation

By Product Type

  • Serum Separation Gel With Integrated Tubes
  • Serum Separation Gel Without Integrated Tubes

By End-use

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Blood Banks
  • Pharmaceutical & Biotechnology Companies
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Serum Separation Gel Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Pipeline Analysis
  • 3.3. Product Type Adoption Analysis
  • 3.4. Value Chain Analysis
  • 3.5. Key Promotional Strategies by Manufacturers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Serum Separation Gel Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Serum Separation Gel Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
    • 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.3.1. Serum Separation Gel With Integrated Tubes
      • 4.3.3.2. Serum Separation Gel Without Integrated Tubes
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Global Serum Separation Gel Market Outlook: End-use
    • 4.4.1. Introduction/Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By End-use, 2019-2024
    • 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
      • 4.4.3.1. Hospitals & Clinics
      • 4.4.3.2. Diagnostic Laboratories
      • 4.4.3.3. Blood Banks
      • 4.4.3.4. Pharmaceutical & Biotechnology Companies
      • 4.4.3.5. Others
    • 4.4.4. Market Attractiveness Analysis: End-use

5. Global Serum Separation Gel Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Serum Separation Gel Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By End-use
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.4.1. Serum Separation Gel With Integrated Tubes
    • 6.4.2. Serum Separation Gel Without Integrated Tubes
  • 6.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 6.5.1. Hospitals & Clinics
    • 6.5.2. Diagnostic Laboratories
    • 6.5.3. Blood Banks
    • 6.5.4. Pharmaceutical & Biotechnology Companies
    • 6.5.5. Others
  • 6.6. Market Attractiveness Analysis

7. Europe Serum Separation Gel Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Product Type
    • 7.2.2. By End-use
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Serum Separation Gel With Integrated Tubes
    • 7.4.2. Serum Separation Gel Without Integrated Tubes
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 7.5.1. Hospitals & Clinics
    • 7.5.2. Diagnostic Laboratories
    • 7.5.3. Blood Banks
    • 7.5.4. Pharmaceutical & Biotechnology Companies
    • 7.5.5. Others
  • 7.6. Market Attractiveness Analysis

8. East Asia Serum Separation Gel Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By End-use
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Serum Separation Gel With Integrated Tubes
    • 8.4.2. Serum Separation Gel Without Integrated Tubes
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 8.5.1. Hospitals & Clinics
    • 8.5.2. Diagnostic Laboratories
    • 8.5.3. Blood Banks
    • 8.5.4. Pharmaceutical & Biotechnology Companies
    • 8.5.5. Others
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Serum Separation Gel Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By End-use
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Serum Separation Gel With Integrated Tubes
    • 9.4.2. Serum Separation Gel Without Integrated Tubes
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 9.5.1. Hospitals & Clinics
    • 9.5.2. Diagnostic Laboratories
    • 9.5.3. Blood Banks
    • 9.5.4. Pharmaceutical & Biotechnology Companies
    • 9.5.5. Others
  • 9.6. Market Attractiveness Analysis

10. Latin America Serum Separation Gel Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By End-use
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Serum Separation Gel With Integrated Tubes
    • 10.4.2. Serum Separation Gel Without Integrated Tubes
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 10.5.1. Hospitals & Clinics
    • 10.5.2. Diagnostic Laboratories
    • 10.5.3. Blood Banks
    • 10.5.4. Pharmaceutical & Biotechnology Companies
    • 10.5.5. Others
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Serum Separation Gel Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By End-use
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Serum Separation Gel With Integrated Tubes
    • 11.4.2. Serum Separation Gel Without Integrated Tubes
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 11.5.1. Hospitals & Clinics
    • 11.5.2. Diagnostic Laboratories
    • 11.5.3. Blood Banks
    • 11.5.4. Pharmaceutical & Biotechnology Companies
    • 11.5.5. Others
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Merck KGaA
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Qiagen N.V.
    • 12.3.3. Cardinal Health Inc.
    • 12.3.4. Medtronic PLC
    • 12.3.5. Bio-Rad Laboratories
    • 12.3.6. Microfluidics International Corporation
    • 12.3.7. BioVision, Inc.
    • 12.3.8. Danaher Corporation
    • 12.3.9. Becton Dickinson & Company
    • 12.3.10. F. Hoffmann-La Roche Ltd.

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations